-
Accelerating Nanotech Innovations Through a Safer-By-Design Approach, Safer Nanomaterials School
14 May 2019 | Contributor(s):: Philippe Sabatier
Nano WG May 9, 2019European Scientific Institute (ESI) Safer Nanomaterials School Introduction.
-
caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine
13 Dec 2013 | | Contributor(s):: Sharon Gaheen, George W Hinkal, Stephanie A Morris, Michal Lijowski, Mervi Heiskanen, Juli Klemm
The use of nanotechnology in biomedicine involves the engineering of nanomaterials to act as therapeutic carriers, targeting agents and diagnostic imaging devices. The application of nanotechnology in cancer aims to transform early detection, targeted therapeutics and cancer prevention and...
-
Development of natural language processing tools for nanoparticle design
05 Mar 2019 | | Contributor(s):: Nastassja Lewinski
Nano WG February 28, 2019: In this presentation, an introduction to the application of natural language processing techniques to nanotechnology data will be discussed. Natural language processing tools can aid in the automatic categorization, extraction, and analysis of data from...
-
Development of Targeted Nanomedicines via Machine Learning Processes
05 Mar 2019 | | Contributor(s):: Daniel Heller
Nano WG February 21, 2019Description: We are using data science to facilitate the development of nanoparticle drugs incorporating kinase inhibitors with diverse chemical structures. Doing this work inspired us to bring together the nanoinformatics community...
-
NCI Alliance for Nanotechnology in Cancer, and caNanoLab: A Data Repository for Cancer Nanomedicines
27 Nov 2018 | | Contributor(s):: Luisa Russell, Mervi Heiskanen
Nano WG presentation November15, 2018 NCI Alliance for Nanotechnology in Cancer –Structure–Achievements–Scientific FocuscaNanoLab–Intro to Platform–Data Curation–User Statistics–Future Directions
-
NCL Method GTA-13
17 Mar 2020 | Datasets | Contributor(s):
By Stephan Stern
In Vitro Blood Partitioning Assay
https://ncihub.cancer.gov/publications/131/?v=1
-
NCL Method IEA-1
09 Jun 2020 | Datasets | Contributor(s):
By Julia Bui1, Edward Cedrone1, Naichen Yu1, Marina Dobrovolskaia
Leidos Biomedical Research, Inc.
Analysis of nanoparticle effects on invasion of cancer cells
https://ncihub.cancer.gov/publications/203/?v=1
-
NCL Method ITA-12
23 Mar 2020 | Datasets | Contributor(s):
By Barry Neun, Jamie Rodriguez, Anna Ilinskaya, Marina Dobrovolskaia
Analysis of Nanoparticle Effects onPlasma Coagulation Times in Vitro
https://ncihub.cancer.gov/publications/147/?v=1
-
NCL Method ITA-12
25 Jun 2020 | Datasets | Contributor(s):
By Edward Cedrone, Timothy Potter, Barry Neun, Marina Dobrovolskaia
In vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time
https://ncihub.cancer.gov/publications/147/?v=2
-
NCL Method ITA-2.1
12 Jun 2020 | Datasets | Contributor(s):
By Barry Neun, Edward Cedrone, Marina Dobrovolskaia
Analysis of Platelet Aggregation By Cell Counting
https://ncihub.cancer.gov/publications/134/?v=2
-
NCL Method ITA-2.2
15 Jun 2020 | Datasets | Contributor(s):
By Jamie Rodriguez, Edward Cedrone, Barry Neun, Marina Dobrovolskaia
Analysis of Platelet Aggregation by Light Transmission Aggregometry
https://ncihub.cancer.gov/publications/135/?v=2
-
NCL Method ITA-5.1
15 Jun 2020 | Datasets | Contributor(s):
By Barry Neun, Edward Cedrone, Marina Dobrovolskaia
Qualitative Analysis of Total Complement Activation by Western Blot
https://ncihub.cancer.gov/publications/138/?v=2
-
NCL Method ITA-8
19 Mar 2020 | Datasets | Contributor(s):
By Sarah Skoczen, Barry Neun, Timothy Potter, Jamie Rodriguez, Anna Ilinskaya, Marina Dobrovolskaia
Chemotaxis Assay
https://ncihub.cancer.gov/publications/142/?v=1
-
NCL Method ITA-8.1
19 Jun 2020 | Datasets | Contributor(s):
By Timothy Potter, Edward Cedrone, Barry Neun, Marina Dobrovolskaia
Chemotaxis Assay
https://ncihub.cancer.gov/publications/208/?v=1
-
NCL Method ITA-8.2
22 Jun 2020 | Datasets | Contributor(s):
By Edward Cedrone, Julia Bui, Naichen Yu, Marina Dobrovolskaia
Analysis of nanoparticle chemoattractant properties using label-free, real-time chemotaxis assay
https://ncihub.cancer.gov/publications/209/?v=1
-
NCL Method PCC-16
02 Apr 2020 | Datasets | Contributor(s):
By Jeffrey Clogston, Mackensie Smith1
Leidos Biomedical Research, Inc.
Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection
https://ncihub.cancer.gov/publications/183/?v=1
-
NCL Method PCC-16
09 Jul 2020 | Datasets | Contributor(s):
By Jeffrey Clogston, Mackensie Smith1
Leidos Biomedical Research, Inc.
Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection
https://ncihub.cancer.gov/publications/183/?v=2
-
NCL Method PCC-17
07 May 2020 | Datasets | Contributor(s):
By Alpana Dongargonkar, Jeffrey Clogston, Alison Vermilya1
Leidos Biomedical Research, Inc.
Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis
https://ncihub.cancer.gov/publications/190/?v=1
-
NCL Method PCC-21
04 Feb 2021 | Datasets | Contributor(s):
By Matthew Hansen, Jeffrey Clogston
Measuring Size and Number Concentration of Metallic Nanoparticles using SP-ICP-MS
https://ncihub.cancer.gov/publications/248/?v=1
-
NCL Method PHA-1
02 Apr 2020 | Datasets | Contributor(s):
By Stephan Stern
Radioactive Blood Partitioning Assay
https://ncihub.cancer.gov/publications/186/?v=1